Here's the NAME & TICKER symbol (and how much you could make from it). ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| A message from Wyatt Investment Research Goldman Sachs (NYSE: GS) says... Johnson & Johnson (NYSE: JNJ) could make you 10%. But that's a small gain compared to what you could make with these 5 hidden stocks. (email required) Go here to see why they could make you 1,355%. (email required) Goldman is recommending investors to buy JNJ in May. They say "the drug and MedTech conglomerate is a stable, defensive grower with the industry's strongest balance sheet." The bank also says JNJ's investments in new high-return medicines will help push revenue higher. Especially when it comes to Stelara... ... which is JNJ's new drug for autoimmune conditions like Crohn's disease and psoriatic arthritis. Goldman sees a 10% upside for the stock. But I'm placing my bets on this hidden opportunity that Jeff Bezos, Bill Gates and Warren Buffett are investing in. (email required) To discover how it could make you a 1,355% gain... Simply go here now for details. (**By clicking the above link you will receive your free report and receive a FREE subscription to the Daily Profit Newsletter.**) Ian Wyatt This is a PAID ADVERTISEMENT provided to the subscribers of Daily Options Signals Free Newsletter. Although we have sent you this email, Daily Options Signals and StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above.
Your privacy is very important to us. If you no longer wish to receive email from DailyOptionsSignals.com, please click Unsubscribe. StockEarnings, Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA W: 877.6.STOCKS StockEarnings.com
Today's Bonus Content: 🌸 10 Stocks to Win in Spring 2025 — FREE Before It's Gone! 📈
(By clicking the link, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.) | | |
|
Tidak ada komentar:
Posting Komentar